Evidence map›Paper›PMID 32122969›Full record

ReviewThe Journal of biological chemistry2020

Heterotrimeric G

Evi Kostenis, Eva Marie Pfeil, Suvi Annala

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Cyclic peptide inhibitors function as molecular glues to stabilize Gq/11 heterotrimers.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. GQ style: a multipronged therapeutic approach to pulmonary arterial hypertension.Pflugers Archiv : European journal of physiology · 2025
    Article
  9. The role of Gαq in regulating NLRP3 inflammasome activation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  10. The G protein inhibitor YM-254890 is an allosteric glue.bioRxiv : the preprint server for biology · 2024
    Article
  11. Review
  12. Stabilization of interdomain closure by a G protein inhibitor.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. G Protein-Coupled Receptors in Cell Signaling Transduction.International journal of molecular sciences · 2023
    Article
  17. Review
  18. Review
  19. The Bacterial GJournal of chemical ecology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Evi KostenisSection of Molecular, Cellular and Pharmacobiology, Institute of Pharmaceutical Biology, Nussallee 6, 53115 Bonn, Germany. Electronic address: kostenis@uni-bonn.de.
Eva Marie PfeilSection of Molecular, Cellular and Pharmacobiology, Institute of Pharmaceutical Biology, Nussallee 6, 53115 Bonn, Germany.
Suvi AnnalaSection of Molecular, Cellular and Pharmacobiology, Institute of Pharmaceutical Biology, Nussallee 6, 53115 Bonn, Germany.
University of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterotrimeric G proteins are the core upstream elements that transduce and amplify the cellular signals from G protein-coupled receptors (GPCRs) to intracellular effectors. GPCRs are the largest family of membrane proteins encoded in the human genome and are the targets of about one-third of prescription medicines. However, to date, no single therapeutic agent exerts its effects via perturbing heterotrimeric G protein function, despite a plethora of evidence linking G protein malfunction to human disease. Several recent studies have brought to light that the G

Indexed as

AnimalsAntineoplastic AgentsDepsipeptidesDrug DiscoveryGTP-Binding Protein alpha Subunits, Gq-G11HumansOncogene ProteinsSignal TransductionAntineoplastic AgentsDepsipeptidesGTP-Binding Protein alpha Subunits, Gq-G11Oncogene Proteinscancercancer biologycancer therapycell signalingFR900359G proteinG protein-coupled receptor (GPCR)GqGq inhibitorheterotrimeric G proteinoncogeneoncoproteinsignalingsignal transductionuveal melanomaYM254890

Identifiers

PMID32122969
PMCPMC7170519
OpenAlexW3009596360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.